AORTIX SYSTEM
Device
Procyrion, Inc.
Total Payments
$2.8M
Transactions
384
Doctors
214
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.5M | 239 | 166 |
| 2023 | $324,948 | 46 | 24 |
| 2022 | $791,692 | 68 | 48 |
| 2021 | $161,417 | 31 | 26 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.6M | 76 | 94.4% |
| Consulting Fee | $141,596 | 28 | 5.1% |
| Food and Beverage | $14,565 | 278 | 0.5% |
| Education | $21.18 | 2 | 0.0% |
Payments by Type
Research
$2.6M
76 transactions
General
$156,182
308 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| DIURETICS ALONE VS. AORTIX ENDOVASCULAR DEVICE FOR ACUTE HEART FAILURE (DRAIN-HF) | PROCYRION, INC. | $1.4M | 0 |
| The Aortix CRS Pilot Study | Procyrion, Inc. | $1.1M | 0 |
| Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure (DRAIN-HF) | Procyrion, Inc. | $102,818 | 0 |
| THE AORTIX CRS PILOT STUDY | PROCYRION, INC. | $15,835 | 0 |
Top Doctors Receiving Payments for AORTIX SYSTEM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Francisco, CA | $2.6M | 76 |
| , M.D., M.S | Advanced Heart Failure and Transplant Cardiology | Falls Church, VA | $37,112 | 4 |
| , MD | Cardiovascular Disease | Boston, MA | $18,638 | 4 |
| , M.D | Internal Medicine | Houston, TX | $14,479 | 4 |
| , MD | Internal Medicine | Charlotte, NC | $12,924 | 3 |
| , M.D | Cardiovascular Disease | Burlington, MA | $9,713 | 3 |
| , M.D | Nephrology | Columbia, SC | $9,286 | 1 |
| , MD | Internal Medicine | Tampa, FL | $8,953 | 6 |
| , M.D | Cardiovascular Disease | Boston, MA | $7,292 | 3 |
| , M.D | Student in an Organized Health Care Education/Training Program | Durham, NC | $6,194 | 4 |
| , MD | Advanced Heart Failure and Transplant Cardiology | Detroit, MI | $6,086 | 7 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Providence, RI | $4,200 | 2 |
| , M.D | Advanced Heart Failure and Transplant Cardiology | Washington, DC | $2,100 | 1 |
| , MD | Internal Medicine | Indianapolis, IN | $2,071 | 1 |
| , MD | Internal Medicine | Nashville, TN | $2,025 | 1 |
| , MD | Cardiovascular Disease | Weston, FL | $1,504 | 4 |
| , M.D | Student in an Organized Health Care Education/Training Program | New York, NY | $750.00 | 1 |
| , MD | Cardiovascular Disease | New York, NY | $406.67 | 4 |
| , D.O | Internal Medicine | Tampa, FL | $390.87 | 3 |
| , MD, MS | Interventional Cardiology | San Francisco, CA | $385.98 | 3 |
| , MD | Cardiovascular Disease | Aurora, CO | $315.52 | 3 |
| , D.O | Internal Medicine | Detroit, MI | $302.91 | 4 |
| , MD | Cardiovascular Disease | Pensacola, FL | $298.86 | 6 |
| Sandeep Nathan | Cardiovascular Disease | Chicago, IL | $294.20 | 4 |
| , MD | Cardiovascular Disease | San Francisco, CA | $284.04 | 2 |
Ad
Manufacturing Companies
- PROCYRION, INC. $1.5M
- Procyrion, Inc. $1.3M
Product Information
- Type Device
- Total Payments $2.8M
- Total Doctors 214
- Transactions 384
About AORTIX SYSTEM
AORTIX SYSTEM is a device associated with $2.8M in payments to 214 healthcare providers, recorded across 384 transactions in the CMS Open Payments database. The primary manufacturer is Procyrion, Inc..
Payment data is available from 2021 to 2024. In 2024, $1.5M was paid across 239 transactions to 166 doctors.
The most common payment nature for AORTIX SYSTEM is "Unspecified" ($2.6M, 94.4% of total).
AORTIX SYSTEM is associated with 4 research studies, including "DIURETICS ALONE VS. AORTIX ENDOVASCULAR DEVICE FOR ACUTE HEART FAILURE (DRAIN-HF)" ($1.4M).